Sanofi reports ‘intermittent supply’ of insulin pens
Sanofi is experiencing “a period of intermittent supply” of its Lantus SoloStar insulin pens in the U.S. amid rising demand, the drugmaker confirmed to Becker’s July 24. Lantus SoloStar is a prefilled pen that delivers insulin glargine, a long-acting insulin used to control blood sugar in people with diabetes. A Sanofi spokesperson attributed the constraint […] The post Sanofi reports ‘intermittent supply’ of insulin pens appeared first on Becker's Hospit...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.